A detailed history of Steward Partners Investment Advisory, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 7,500 shares of RCKT stock, worth $130,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,500
Previous 7,500 -0.0%
Holding current value
$130,875
Previous $202,000 20.3%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$26.16 - $30.74 $65,400 - $76,850
2,500 Added 50.0%
7,500 $202,000
Q3 2023

Nov 13, 2023

BUY
$15.07 - $24.05 $7,535 - $12,025
500 Added 11.11%
5,000 $102,000
Q1 2023

May 15, 2023

BUY
$15.79 - $22.6 $39,475 - $56,500
2,500 Added 125.0%
4,500 $77,000
Q4 2022

Feb 15, 2023

BUY
$15.5 - $22.76 $31,000 - $45,520
2,000 New
2,000 $39,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.32B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.